Putting the PASC Score to the Test: Clinical vs. Statistical Accuracy in Long COVID Diagnosis - Scorecard - MDSpire

Putting the PASC Score to the Test: Clinical vs. Statistical Accuracy in Long COVID Diagnosis

  • By

  • Alba Azola

  • Raha M. Dastgheyb

  • Rebecca Easter

  • Hannah Parker

  • Christina Della Penna

  • Isabel Santiuste

  • Holly Schultz

  • Ana Ehrenspeck

  • Rebecca Veenhuis

  • Leah H. Rubin

  • November 17, 2025

  • 0 min

Share

Clinical Scorecard: Evaluating the PASC Score: Comparing Clinical and Statistical Effectiveness in Diagnosing Long COVID

At a Glance

CategoryDetail
Condition
Key MechanismsInfection-associated chronic condition characterized by multisystemic symptoms lasting at least 3 months, as per NASEM 2024.
Target Population
Care Setting

Key Highlights

  • 1

Guideline-Based Recommendations

Diagnosis

  • Utilize the PASC score for symptom assessment.
  • Consider NASEM 2024 definition for diagnosing long COVID, which includes specific criteria.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Focus on symptom management and supportive care tailored to individual needs, including cognitive behavioral therapy and physical rehabilitation.

        Clinical Best Practices

        • 1

        References

        Original Source(s)

        Putting the PASC Score to the Test: Clinical vs. Statistical Accuracy in Long COVID Diagnosis

        • by Alba Azola, Raha M. Dastgheyb, Rebecca Easter, Hannah Parker, Christina Della Penna, Isabel Santiuste, Holly Schultz, Ana Ehrenspeck, Rebecca Veenhuis, Leah H. Rubin

        • November 17, 2025

        Related Content

        Evaluating the Diagnostic Efficacy and Results of Comprehensive SARS-CoV-2 Testing in Asymptomatic Individuals

        Recent COVID-19 Shot Linked to Less Spread

        Protection against spread appeared strongest within 6 months of vaccination, while exposed vaccinated contacts showed no measurable reduction in infection risk.

        Safety, immunogenicity, and long COVID outcomes following inactivated COVID-19 vaccine boosters in elderly Chinese: a prospective cohort study